Cognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer
Recruiting · NCT06687291 · Observational (researchers observe without assigning treatment) · Lead sponsor: Karolinska Institutet
View the official record on ClinicalTrials.gov →What this trial is about
The primary objective of this observational study is to investigate the incidence of Post Operative Delirium (POD) after gastroesophageal cancer surgery. Secondary objectives are to investigate the relationship between POD, preoperative depression, frailty, quality of life, malnutrition and sarcopenia. Participants identified with POD will be asked (at the routine follow-up meeting after surgery) to participate in an qualitative interview, in order to understand the participant's experience of postoperative delirium. The main objective aims to answer: What is the incidence of POD after gastroesophageal cancer surgery.
Who can take part
Inclusion criteria
- Patients diagnosed with esophageal or gastric cancer, treated with (or without) chemotherapy and surgery.
- Age ≥18 at the time for inclusion.
- Participate on a voluntary basis and can (for any reason) end its participation during the study.
- Capable of giving informed consent.
Exclusion criteria
- Patients with preoperative cognitive dysfunction such as dementia.
- Patients who are inoperable due to metastases.
- Patients unable to communicate due to severely impaired hearing and/or - seeing.
- Patients with ongoing drug and/or alcohol abuse.
- Patients who cannot give informed consent.
Where it is running
1 location listed.
- Karolinska University Hospital, Huddinge - Huddinge, Sweden